Phytotherapeutic Approaches to Metabolic Disorders: Evidence, Mechanisms, and Translational Potential

Abstract

Sedentary lifestyles, dietary habits, and genetic factors have led to metabolic disorders such as diabetes mellitus, obesity, and cardiovascular diseases becoming major global health concerns. The conventional pharmacotherapies, while effective, often come with significant limitations of high cost, adverse effects, and poor patient compliance. Medicinal plants provide a feasible alternative that is safer and more economical due to their diverse bioactive phytochemicals that act synergistically to produce therapeutic benefits. This review highlights the pharmacological potential of medicinal plants in the management of metabolic disorders with an emphasis on mechanisms of action, efficacy, and clinical relevance. Key botanicals, including Momordica charantia, Vaccinium angustifolium, Crataegus laevigata, Hoodia gordonii, Trigonella foenum-graecum, Artemisia dracunculus, and Cinnamomum cassia, have exhibited significant roles in enhancing insulin sensitivity, reducing hyperglycemia, modulating lipid metabolism, and controlling hypertension. Additionally, Allium sativum, Coriandrum sativum, and Tribulus terrestris are some of the plants that possess cardioprotective and antihypertensive activities. Despite encouraging preclinical and clinical results, standardization, quality control, and toxicity studies still pose challenges for herbal products. Further scientific validation and integration of traditional knowledge with modern pharmacology will be required to fully realize the therapeutic potential of medicinal plants in metabolic disorders.